Cancer Diagnostics Market Size, Share, Analysis, Growth, Trends, Industry Report 2023-2032|Abbott Laboratories, Becton Dickinson and Company, Hologic, GE Healthcare Ltd., Thermo Fisher Scientific,

Woman Receiving Radiation Therapy Treatments for Breast Cancer

The Cancer Diagnostics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2011-2022) and extends its insights into a ten-year forecast period (2024-2033).

Learn More On The Cancer Diagnostics Market:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

According to The Business Research Company’s Cancer Diagnostics Global Market Report 2024, The cancer diagnostics market size has grown rapidly in recent years. It will grow from $21.38 billion in 2023 to $23.84 billion in 2024 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to increasing cancer incidence, cancer screening programs, personalized medicine, public awareness.

The cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $37.09 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to emerging markets growth, regulatory support, artificial intelligence (ai) and machine learning, early detection and intervention. Major trends in the forecast period include liquid biopsies, multi-omics approaches, point-of-care testing, screening and early intervention campaigns.

A high prevalence rate of various types of cancers is a major driver of the cancer diagnostics market. This is because the increasing incidences of various types of cancers are leading to a greater number of people opting for diagnosis and treatment. In addition, according to the World Health Organization (WHO), cancer was the second-leading cause of death worldwide. The National Cancer Institute (NCI) has estimated the number of new cancer cases per year to reach 23.6 million by 2030.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=2570&type=smp

The cancer diagnostics market covered in this report is segmented –

1) By Products: Companion Diagnostics; Molecular Diagnostics

2) By Method: Biopsy; Endoscopy; Tumor Biomarker Tests; Imaging

3) By Application: Cervical Cancer; Breast Cancer; Liver Cancer; Blood Cancer; Kidney Cancer; Colorectal Cancer; Pancreatic Cancer; Ovarian Cancer; Melanoma; Other Applications

4) By End-User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals; Other End Users

The cancer diagnostics market report table of contents includes:

1. Executive Summary

2. Cancer Diagnostics Market Characteristics

3. Cancer Diagnostics Market Trends And Strategies

4. Cancer Diagnostics Market – Macro Economic Scenario

5. Global Cancer Diagnostics Market Size and Growt

26. South America Cancer Diagnostics Market

27. Brazil Cancer Diagnostics Market

28. Middle East Cancer Diagnostics Market

29. Africa Cancer Diagnostics Market

30. Cancer Diagnostics Market Competitive Landscape And Company Profiles